浅谈《医疗器械注册自检管理规定》检查实践之体外诊断试剂

      A Brief Discussion on the in Vitro Diagnostic Reagent Inspection Practice of Self-examination Management Regulations for Medical Device Registration

      • 摘要: 2021年10月21日,国家药品监督管理局发布并实施了《医疗器械注册自检管理规定》。该《规定》明确了注册申请人在注册自检工作开展过程中的具体要求,并从自检能力、自检报告、申报资料、责任要求等方面提出了细化要求,以确保医疗器械注册自检工作的有序开展。该研究结合体外诊断试剂的实际核查工作浅谈了对于该《规定》相关内容的理解,旨在给有注册自检需求的企业和相关的监管部门提供一定参考。

         

        Abstract: On October 21, 2021, the National Medical Products Administration issued and implemented the Self-examination Management Regulations for Medical Device Registration. The regulations clarify the specific requirements of the registration applicants in the process of self-examination, and put forward detailed requirements from the aspects of self-examination ability, self-examination report, declaration materials and responsibility requirements, so as to ensure the orderly development of the self-examination of medical device registration. Based on the actual verification work of in vitro diagnostic reagent, this study briefly discussed the understanding of the relevant contents of the regulations, aiming to provide some reference for enterprises and related supervision departments that have the requirement of registered self-examination.

         

      /

      返回文章
      返回